Cargando…
Molecular characterization of signalling pathways in cancer stem cells
To avoid artefacts introduced by culturing cells for extended periods of time, it is crucial to use low-passage patient-derived tumour cells. The ability to enrich, isolate and assay sub-populations of cells that behave as cancer stem cells (CSCs) from these primary cell lines is essential before pe...
Autores principales: | Regenbrecht, C, Welte, Y, Jodicke, A, Hugel, R, Walden, P, Jung, M, Lehrach, H, Adjaye, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234046/ https://www.ncbi.nlm.nih.gov/pubmed/22275988 http://dx.doi.org/10.3332/ecancer.2008.115 |
Ejemplares similares
-
Cancer stem cells in melanoma
por: Regenbrecht, C, et al.
Publicado: (2008) -
Erratum: Cancer stem cells in melanoma
por: Regenbrecht, C, et al.
Publicado: (2012) -
Cancer stem cells in solid tumors: elusive or illusive?
por: Welte, Yvonne, et al.
Publicado: (2010) -
Stemming Cancer: Functional Genomics of Cancer Stem Cells in Solid Tumors
por: Regenbrecht, C. R. A., et al.
Publicado: (2008) -
The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines
por: Regenbrecht, Christian RA, et al.
Publicado: (2008)